These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 17009629)
1. Does shifting a physician payment system shift physician priorities? A multi-site evaluation of an alternative payment plan (APP) for gynecologic oncologists in Ontario. Elit L; Cosby J; Eur J Gynaecol Oncol; 2006; 27(4):375-8. PubMed ID: 17009629 [TBL] [Abstract][Full Text] [Related]
2. An analysis of alternative funding for physicians practicing gynecologic oncology in Ontario, Canada prior to 2001. Elit L Eur J Gynaecol Oncol; 2006; 27(1):61-4. PubMed ID: 16550972 [TBL] [Abstract][Full Text] [Related]
3. Medical ethics: enhanced or undermined by modes of payment? Zweifel P; Janus K Eur J Health Econ; 2017 Jan; 18(1):119-129. PubMed ID: 27072055 [TBL] [Abstract][Full Text] [Related]
4. For Medicare's New Approach To Physician Payment, Big Questions Remain. Wynne B Health Aff (Millwood); 2016 Sep; 35(9):1643-6. PubMed ID: 27605645 [TBL] [Abstract][Full Text] [Related]
5. Challenges, Perceptions, and Readiness of Oncology Clinicians for the MACRA Quality Payment Program. Nabhan C; Jeune-Smith Y; Klinefelter P; Kelly RJ; Feinberg BA JAMA Oncol; 2018 Feb; 4(2):252-253. PubMed ID: 29167859 [TBL] [Abstract][Full Text] [Related]
6. Ambulatory care prospective payment: the effect on clinical practice patterns. Aquavella JV J Ambul Care Manage; 1993 Apr; 16(2):65-70. PubMed ID: 10171406 [TBL] [Abstract][Full Text] [Related]
7. Prospective payment and medical ethics. Begley CE J Med Philos; 1987 May; 12(2):107-22. PubMed ID: 3598410 [TBL] [Abstract][Full Text] [Related]
8. Risk selection and cost shifting in a prospective physician payment system: evidence from Ontario. Kantarevic J; Kralj B Health Policy; 2014 Apr; 115(2-3):249-57. PubMed ID: 24210763 [TBL] [Abstract][Full Text] [Related]
10. Common patterns of corporate dermatology billing abuses in Medicare data sets. Francis JK Clin Dermatol; 2020; 38(3):284-288. PubMed ID: 32563338 [TBL] [Abstract][Full Text] [Related]
12. Provider behavior under prospective reimbursement. Cost sharing and supply. Ellis RP; McGuire TG J Health Econ; 1986 Jun; 5(2):129-51. PubMed ID: 10287223 [TBL] [Abstract][Full Text] [Related]
13. Variations in physician practice and covert rationing. Feinglass J Theor Med; 1987 Feb; 8(1):31-45. PubMed ID: 3551179 [No Abstract] [Full Text] [Related]
14. The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative study. Berry SR; Hubay S; Soibelman H; Martin DK BMC Health Serv Res; 2007 Nov; 7():193. PubMed ID: 18042302 [TBL] [Abstract][Full Text] [Related]
15. Physicians' perceptions of the effect on clinical services of an alternative funding plan at an academic health sciences centre. Godwin M; Shortt S; McIntosh L; Bolton C CMAJ; 1999 Jun; 160(12):1710-4. PubMed ID: 10410632 [TBL] [Abstract][Full Text] [Related]
16. Are oncologists' financial incentives aligned with quality care? Wong YN J Clin Oncol; 2013 Feb; 31(5):517-9. PubMed ID: 23269998 [No Abstract] [Full Text] [Related]
17. Getting the next version of payment policy "right" on the road toward accountable cancer care. Bekelman JE; Epstein AJ; Emanuel EJ Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):954-957. PubMed ID: 25035198 [No Abstract] [Full Text] [Related]